Articles

Micro-ribonucleic acid-155 is a direct target of Meis1, but not a driver in acute myeloid leukemia

Department of Internal Medicine III, University Hospital of Ulm, Germany
Department of Clinical Chemistry and Transfusion Medicine, Institute of Biomedicine, Sahlgrenska Academy at University of Gothenburg, Sweden
Department of Internal Medicine III, University Hospital of Ulm, Germany
Department of Clinical Chemistry and Transfusion Medicine, Institute of Biomedicine, Sahlgrenska Academy at University of Gothenburg, Sweden
Institute of Biomedicine, University of Gothenburg, Sweden
Department of Internal Medicine III, University Hospital of Ulm, Germany
Department of Internal Medicine III, University Hospital of Ulm, Germany
Department of Internal Medicine III, University Hospital of Ulm, Germany
Department of Clinical Chemistry and Transfusion Medicine, Institute of Biomedicine, Sahlgrenska Academy at University of Gothenburg, Sweden;Department of Medicine, Sahlgrenska University Hospital, Gothenburg, Sweden
Department of Clinical Chemistry and Transfusion Medicine, Institute of Biomedicine, Sahlgrenska Academy at University of Gothenburg, Sweden
Institute of Experimental Cancer Research, Comprehensive Cancer Centre Ulm, Germany
Department of Internal Medicine III, University Hospital of Ulm, Germany
Department of Internal Medicine III, University Hospital of Ulm, Germany
Department of Clinical Chemistry and Transfusion Medicine, Institute of Biomedicine, Sahlgrenska Academy at University of Gothenburg, Sweden;Department of Clinical Chemistry, Sahlgrenska University Hospital, Gothenburg, Sweden
Department of Hematology, Homeostasis, Oncology and Stem Cell Transplantation, Hannover Medical School, Germany
Department of Internal Medicine III, University Hospital of Ulm, Germany
Terry Fox Laboratory, British Columbia Cancer Agency, Vancouver, BC, Canada
Terry Fox Laboratory, British Columbia Cancer Agency, Vancouver, BC, Canada
Department of Physics and Astronomy, University of British Columbia, Vancouver, BC, Canada
Canada’s Michael Smith Genome Sciences Centre, British Columbia Cancer Agency, Vancouver, BC, Canada
Centre for High-Throughput Biology, University of British Columbia, Vancouver, BC, Canada
Canada’s Michael Smith Genome Sciences Centre, British Columbia Cancer Agency, Vancouver, BC, Canada;Centre for High-Throughput Biology, University of British Columbia, Vancouver, BC, Canada
Terry Fox Laboratory, British Columbia Cancer Agency, Vancouver, BC, Canada
Department of Internal Medicine III, University Hospital of Ulm, Germany
Department of Clinical Chemistry and Transfusion Medicine, Institute of Biomedicine, Sahlgrenska Academy at University of Gothenburg, Sweden;Department of Clinical Chemistry, Sahlgrenska University Hospital, Gothenburg, Sweden
Department of Internal Medicine III, University Hospital of Ulm, Germany;Institute of Experimental Cancer Research, Comprehensive Cancer Centre Ulm, Germany
Vol. 103 No. 2 (2018): February, 2018 https://doi.org/10.3324/haematol.2017.177485